Exogenous KLF5 promotes TSU-pr1 bladder cancer cell growth in vitro and in vivo, which is consistent with our results that knockdown of KLF5 leads to the down-regulation of cyclin D1 and a decrease of the cell proliferation of 5637 bladder cancer cells (Figure 3). The gene discussed is CCND1; the disease is urinary bladder carcinoma.